Table 2.
Laboratory characteristics of all patients according to outcome.
| Characteristics | All patients | Survivors | Nonsurvivors | p value |
|---|---|---|---|---|
| WBC count (109/L) | 12.74 ± 5.59 | 12.91 ± 5.31 | 12.53 ± 5.91 | p = 0.312 |
| Neutrophil (109/L) | 10.40 (7.32–13.42) | 10.30 (7.30–13.75) | 10.40 (7.40–13.05) | p = 0.728 |
| Lymphocyte (109/L) | 0.95 (0.61–1.31) | 1.06 (0.77–1.45) | 0.81 (0.55–1.20) | p ≤ 0.001∗∗ |
| Monocyte (109/L) | 0.60 (0.35–0.92) | 0.64 (0.40–1.03) | 0.56 (0.29–0.80) | p ≤ 0.001∗∗ |
| Platelet (109/L) | 241.63 ± 152.29 | 267.41 ± 156.04 | 210.94 ± 142.15 | p ≤ 0.001∗∗ |
| MPV (fL) | 9.05 ± 1.76 | 8.61 ± 1.27 | 9.61 ± 2.11 | p ≤ 0.001∗∗ |
| MPV/PC ratio (fL 10−5 μL−1) | 3.7 (2.5–6.2) | 3.4 (2.3–5.3) | 4.7 (3.0–8.0) | p ≤ 0.001∗∗ |
| NLR | 11.00 (7.02–15.71) | 9.91 (6.17–13.78) | 12.26 (7.72–18.25) | p = 0.001∗∗ |
| MLR | 0.61 (0.38–1.02) | 0.62 (0.37–1.02) | 0.58 (0.39–1.01) | p = 0.240 |
| PLR | 226.53 (162.16–354.20) | 228.38 (152.71–328.59) | 225.11 (166.47–410.40) | p = 0.848 |
Data are shown as number (%), mean (standard deviation, SD), or median (interquartile range, IQR) as appropriate. Significant differences are marked by ∗∗ (p < 0.01).